 | • レポートコード：MRC2-11QY04468 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は組換え凝固因子のグローバル市場について調査・分析したレポートです。種類別（リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター）市場規模、用途別（病院、診療所、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別組換え凝固因子の競争状況、市場シェア ・世界の組換え凝固因子市場：種類別市場規模 2015年-2020年（リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター） ・世界の組換え凝固因子市場：種類別市場規模予測 2021年-2026年（リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター） ・世界の組換え凝固因子市場：用途別市場規模 2015年-2020年（病院、診療所、研究機関） ・世界の組換え凝固因子市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究機関） ・北米の組換え凝固因子市場分析：米国、カナダ ・ヨーロッパの組換え凝固因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの組換え凝固因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の組換え凝固因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの組換え凝固因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter International Inc.、Bayer AG、Biogen Idec、CSL Ltd.、Grifols International SA、Kedrion S.P.A.、Novo Nordisk A/S、Octapharma AG、Pfizer Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
Market Analysis and Insights: Global Recombinant Coagulation Factors Market
The global Recombinant Coagulation Factors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Recombinant Coagulation Factors Scope and Market Size
Recombinant Coagulation Factors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Coagulation Factors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
Market segment by Type, the product can be split into
Recombinant Factor VIII
Recombinant Factor IX
Von Willebrand Factor
Market segment by Application, split into
Hospitals
Clinics
Research Organizations
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Coagulation Factors Revenue
1.4 Market by Type
1.4.1 Global Recombinant Coagulation Factors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Recombinant Factor VIII
1.4.3 Recombinant Factor IX
1.4.4 Von Willebrand Factor
1.5 Market by Application
1.5.1 Global Recombinant Coagulation Factors Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Coagulation Factors Market Perspective (2015-2026)
2.2 Global Recombinant Coagulation Factors Growth Trends by Regions
2.2.1 Recombinant Coagulation Factors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant Coagulation Factors Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant Coagulation Factors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant Coagulation Factors Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Coagulation Factors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Coagulation Factors Players by Market Size
3.1.1 Global Top Recombinant Coagulation Factors Players by Revenue (2015-2020)
3.1.2 Global Recombinant Coagulation Factors Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Coagulation Factors Market Concentration Ratio
3.2.1 Global Recombinant Coagulation Factors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factors Revenue in 2019
3.3 Recombinant Coagulation Factors Key Players Head office and Area Served
3.4 Key Players Recombinant Coagulation Factors Product Solution and Service
3.5 Date of Enter into Recombinant Coagulation Factors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Recombinant Coagulation Factors Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Coagulation Factors Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Recombinant Coagulation Factors Market Size by Application (2015-2020)
5.2 Global Recombinant Coagulation Factors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Recombinant Coagulation Factors Market Size (2015-2020)
6.2 Recombinant Coagulation Factors Key Players in North America (2019-2020)
6.3 North America Recombinant Coagulation Factors Market Size by Type (2015-2020)
6.4 North America Recombinant Coagulation Factors Market Size by Application (2015-2020)
7 Europe
7.1 Europe Recombinant Coagulation Factors Market Size (2015-2020)
7.2 Recombinant Coagulation Factors Key Players in Europe (2019-2020)
7.3 Europe Recombinant Coagulation Factors Market Size by Type (2015-2020)
7.4 Europe Recombinant Coagulation Factors Market Size by Application (2015-2020)
8 China
8.1 China Recombinant Coagulation Factors Market Size (2015-2020)
8.2 Recombinant Coagulation Factors Key Players in China (2019-2020)
8.3 China Recombinant Coagulation Factors Market Size by Type (2015-2020)
8.4 China Recombinant Coagulation Factors Market Size by Application (2015-2020)
9 Japan
9.1 Japan Recombinant Coagulation Factors Market Size (2015-2020)
9.2 Recombinant Coagulation Factors Key Players in Japan (2019-2020)
9.3 Japan Recombinant Coagulation Factors Market Size by Type (2015-2020)
9.4 Japan Recombinant Coagulation Factors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Recombinant Coagulation Factors Market Size (2015-2020)
10.2 Recombinant Coagulation Factors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Coagulation Factors Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Coagulation Factors Market Size by Application (2015-2020)
11 India
11.1 India Recombinant Coagulation Factors Market Size (2015-2020)
11.2 Recombinant Coagulation Factors Key Players in India (2019-2020)
11.3 India Recombinant Coagulation Factors Market Size by Type (2015-2020)
11.4 India Recombinant Coagulation Factors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Recombinant Coagulation Factors Market Size (2015-2020)
12.2 Recombinant Coagulation Factors Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Coagulation Factors Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Coagulation Factors Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Baxter International Inc.
13.1.1 Baxter International Inc. Company Details
13.1.2 Baxter International Inc. Business Overview
13.1.3 Baxter International Inc. Recombinant Coagulation Factors Introduction
13.1.4 Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020))
13.1.5 Baxter International Inc. Recent Development
13.2 Bayer AG
13.2.1 Bayer AG Company Details
13.2.2 Bayer AG Business Overview
13.2.3 Bayer AG Recombinant Coagulation Factors Introduction
13.2.4 Bayer AG Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.2.5 Bayer AG Recent Development
13.3 Biogen Idec
13.3.1 Biogen Idec Company Details
13.3.2 Biogen Idec Business Overview
13.3.3 Biogen Idec Recombinant Coagulation Factors Introduction
13.3.4 Biogen Idec Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.3.5 Biogen Idec Recent Development
13.4 CSL Ltd.
13.4.1 CSL Ltd. Company Details
13.4.2 CSL Ltd. Business Overview
13.4.3 CSL Ltd. Recombinant Coagulation Factors Introduction
13.4.4 CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.4.5 CSL Ltd. Recent Development
13.5 Grifols International SA
13.5.1 Grifols International SA Company Details
13.5.2 Grifols International SA Business Overview
13.5.3 Grifols International SA Recombinant Coagulation Factors Introduction
13.5.4 Grifols International SA Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.5.5 Grifols International SA Recent Development
13.6 Kedrion S.P.A.
13.6.1 Kedrion S.P.A. Company Details
13.6.2 Kedrion S.P.A. Business Overview
13.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Introduction
13.6.4 Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.6.5 Kedrion S.P.A. Recent Development
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S Company Details
13.7.2 Novo Nordisk A/S Business Overview
13.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Introduction
13.7.4 Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.7.5 Novo Nordisk A/S Recent Development
13.8 Octapharma AG
13.8.1 Octapharma AG Company Details
13.8.2 Octapharma AG Business Overview
13.8.3 Octapharma AG Recombinant Coagulation Factors Introduction
13.8.4 Octapharma AG Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.8.5 Octapharma AG Recent Development
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Details
13.9.2 Pfizer Inc. Business Overview
13.9.3 Pfizer Inc. Recombinant Coagulation Factors Introduction
13.9.4 Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020)
13.9.5 Pfizer Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Recombinant Coagulation Factors Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Coagulation Factors Revenue
Table 3. Ranking of Global Top Recombinant Coagulation Factors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Coagulation Factors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Recombinant Factor VIII
Table 6. Key Players of Recombinant Factor IX
Table 7. Key Players of Von Willebrand Factor
Table 8. Global Recombinant Coagulation Factors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Recombinant Coagulation Factors Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Recombinant Coagulation Factors Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Recombinant Coagulation Factors Market Share by Regions (2015-2020)
Table 12. Global Recombinant Coagulation Factors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Recombinant Coagulation Factors Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Recombinant Coagulation Factors Market Growth Strategy
Table 18. Main Points Interviewed from Key Recombinant Coagulation Factors Players
Table 19. Global Recombinant Coagulation Factors Revenue by Players (2015-2020) (Million US$)
Table 20. Global Recombinant Coagulation Factors Market Share by Players (2015-2020)
Table 21. Global Top Recombinant Coagulation Factors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factors as of 2019)
Table 22. Global Recombinant Coagulation Factors by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Recombinant Coagulation Factors Product Solution and Service
Table 25. Date of Enter into Recombinant Coagulation Factors Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 28. Global Recombinant Coagulation Factors Market Size Share by Type (2015-2020)
Table 29. Global Recombinant Coagulation Factors Revenue Market Share by Type (2021-2026)
Table 30. Global Recombinant Coagulation Factors Market Size Share by Application (2015-2020)
Table 31. Global Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 32. Global Recombinant Coagulation Factors Market Size Share by Application (2021-2026)
Table 33. North America Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 35. North America Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 36. North America Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 37. North America Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 38. North America Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 39. Europe Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 41. Europe Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 43. Europe Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 45. China Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 46. China Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 47. China Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 48. China Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 49. China Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 50. China Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 51. Japan Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 53. Japan Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 55. Japan Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 59. Southeast Asia Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 61. Southeast Asia Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 63. India Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 64. India Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 65. India Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 66. India Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 67. India Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 68. India Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 71. Central & South America Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 73. Central & South America Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 75. Baxter International Inc. Company Details
Table 76. Baxter International Inc. Business Overview
Table 77. Baxter International Inc. Product
Table 78. Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 79. Baxter International Inc. Recent Development
Table 80. Bayer AG Company Details
Table 81. Bayer AG Business Overview
Table 82. Bayer AG Product
Table 83. Bayer AG Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 84. Bayer AG Recent Development
Table 85. Biogen Idec Company Details
Table 86. Biogen Idec Business Overview
Table 87. Biogen Idec Product
Table 88. Biogen Idec Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 89. Biogen Idec Recent Development
Table 90. CSL Ltd. Company Details
Table 91. CSL Ltd. Business Overview
Table 92. CSL Ltd. Product
Table 93. CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 94. CSL Ltd. Recent Development
Table 95. Grifols International SA Company Details
Table 96. Grifols International SA Business Overview
Table 97. Grifols International SA Product
Table 98. Grifols International SA Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 99. Grifols International SA Recent Development
Table 100. Kedrion S.P.A. Company Details
Table 101. Kedrion S.P.A. Business Overview
Table 102. Kedrion S.P.A. Product
Table 103. Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 104. Kedrion S.P.A. Recent Development
Table 105. Novo Nordisk A/S Company Details
Table 106. Novo Nordisk A/S Business Overview
Table 107. Novo Nordisk A/S Product
Table 108. Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 109. Novo Nordisk A/S Recent Development
Table 110. Octapharma AG Business Overview
Table 111. Octapharma AG Product
Table 112. Octapharma AG Company Details
Table 113. Octapharma AG Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 114. Octapharma AG Recent Development
Table 115. Pfizer Inc. Company Details
Table 116. Pfizer Inc. Business Overview
Table 117. Pfizer Inc. Product
Table 118. Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 119. Pfizer Inc. Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Coagulation Factors Market Share by Type: 2020 VS 2026
Figure 2. Recombinant Factor VIII Features
Figure 3. Recombinant Factor IX Features
Figure 4. Von Willebrand Factor Features
Figure 5. Global Recombinant Coagulation Factors Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Organizations Case Studies
Figure 9. Recombinant Coagulation Factors Report Years Considered
Figure 10. Global Recombinant Coagulation Factors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Recombinant Coagulation Factors Market Share by Regions: 2020 VS 2026
Figure 12. Global Recombinant Coagulation Factors Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Recombinant Coagulation Factors Market Share by Players in 2019
Figure 15. Global Top Recombinant Coagulation Factors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factors as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Coagulation Factors Revenue in 2019
Figure 17. North America Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…- 治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 凝固XI因子の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor XI Scope and Market Size Coagulation Factor XI marke…
- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…
- ヒト凝固因子IXの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IX Market The global Human Coagulation Factor IX market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IX Scope and Market Size Human Coa…